Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/OMEROS-CORPORATION-5628248/news/Omeros-CMS-Confirms-Continued-Separate-Payment-for-Omeros-FDA-Approved-OMIDRIA-in-Ambulatory-31928553/?utm_source=whatsapp&utm_medium=social&utm_campaign=share